Obstetrics, gynecology and reproductive medicine guidelines

Breast diseases

PubMed Free Full Text

Breast cancer treatment: tyrosine kinase inhibitors

United Kingdom

• Health Technology Assessment
  • Lapatinib for the treatment of HER2-overexpressing breast cancer [2009]

• National Institute for Health and Clinical Excellence
  • Breast cancer (advanced or metastatic) - lapatinib [2008]

Articles in journals

• Annals of Oncology
  • Targeting Src in breast cancer [2008]
  • Lapatinib in breast cancer [2007]

• Breast Cancer
  • Does lapatinib, a small-molecule tyrosine kinase inhibitor, constitute a breakthrough in the treatment of breast cancer? [2007]

• Endocrine-Related Cancer
  • Overview of tyrosine kinase inhibitors in clinical breast cancer [2005]
  • Clinical trials of intracellular signal transductions inhibitors for breast cancer -- a strategy to overcome endocrine resistance [2005]

• Sao Paulo Medical Journal
  • Lapatinib for treatment of advanced or metastasized breast cancer: systematic review [2010]

{Related topics}

• Guidelines
  • Breast cancer treatment